Treatment regimens in non-small cell lung cancer are no longer neatly divided into surgery for early disease and chemo-radiotherapy for advanced disease. We are in an era of cross speciality integration in all disease stages of lung cancer. Thoracic Oncology 2019 focuses on the transition from current to future practice with a superb international faculty delivering short presentations accompanied by an interactive audience participation in discussions, questions and answers.
It’s your opportunity to interact with the experts to determine their views on the future landscape for the management in thoracic oncology, in a conference is designed to target surgeons, oncologists, chest physicians, the wider multi-disciplinary team including trainees in the management of lung cancer.
It’s a great honour and privilege for me to invite you to join us in London on the 28 and 29 November 2019!
Professor Eric Lim
Royal Brompton Hospital, London, United Kingdom